Evidence map›Paper›PMID 21070478›Full record

ArticleCancer science2011

Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal.

Zhiyan Liu, Gengyin Zhou, Misa Nakamura, Eisuke Koike, Yaqiong Li, Takashi Ozaki, Ichiro Mori, Emiko Taniguchi, Kennichi Kakudo

Open access · bronzeAbstract read
In one paragraph

Article in Cancer science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Encapsulated neoplasms of the thyroid gland.Virchows Archiv : an international journal of pathology · 2026
    Review
  5. Article
  6. The Asian Thyroid Working Group, from 2017 to 2023.Journal of pathology and translational medicine · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Prevalence ofJournal of Korean medical science · 2018
    Article
  18. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2018
    Review
  19. Preoperative Molecular Markers in Thyroid Nodules.Frontiers in endocrinology · 2018
    Review
  20. Current Practices of Thyroid Fine-Needle Aspiration in Asia: A Missing Voice.Journal of pathology and translational medicine · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Zhiyan LiuDepartment of Human Pathology, Wakayama Medical University, Wakayama City, Japan.
Gengyin Zhou
Misa Nakamura
Eisuke Koike
Yaqiong Li
Takashi Ozaki
Ichiro Mori
Emiko Taniguchi
Kennichi Kakudo
Wakayama Medical University · JPShandong University · CNOsaka Kawasaki Rehabilitation University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a continuous debate regarding the classification of thyroid follicular lesions and the term "well-differentiated tumor of uncertain malignant potential (WDT-UMP)" was recently introduced to cover this problematic spectrum of tumors. The objective of this study was to reappraise WDT-UMP using morphological, immunochemical, and molecular analysis and to shed more light on encapsulated thyroid follicular-patterned tumors. A total of 30 cases of WDT-UMP with equivocal papillary thyroid carcinoma-type nuclear changes (PTC-N) or focal unequivocal PTC-N were examined. As a control, follicular adenoma (n = 29), follicular carcinoma (n = 8), hyalinizing trabecular adenoma (n = 5), and PTC (n = 48) were included. HBME-1, cytokeratin 19, and galectin-3 were positive in 12 (40.0%), 10 (33.3%) and 11 (36.7%) cases of WDT-UMP, respectively. According to the positivity of those markers, significant differences were obtained between WDT-UMP and PTC encapsulated common type (P = 0.028, 0.010, and 0.004, respectively), infiltrative follicular variant (P = 0.020, 0.026, and 0.008, respectively), and infiltrative common type (P = 0.004, 0.001, and 0.005, respectively), but not between WDT-UMP and follicular adenoma or follicular carcinoma. BRAF(V600E) mutation was absent but RET/PTC1 rearrangement was found in only two (6.7%) cases of WDT-UMP. None of the 20 patients with WDT-UMP developed recurrence, with an average follow-up of 80 months. These findings indicate that WDT-UMP has a favorable outcome and is distinct from PTC in morphological, immunohistochemical, and molecular characteristics. We propose that WDT-UMP should be classified as "well-differentiated tumor with uncertain behavior".

Indexed as

Adenocarcinoma, FollicularAdultAgedAged, 80 and overAntigens, NeoplasmBiomarkers, TumorCell DifferentiationCell NucleusFemaleGalectin 3HumansImmunohistochemistryKeratin-19MaleMiddle AgedThyroid NeoplasmsAntigens, NeoplasmBiomarkers, TumorGalectin 3HBME-1 antigenKeratin-19

Identifiers

PMID21070478
PMCPMC11159267
OpenAlexW2047189534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.